# Impact of APP-assisted Patient Management on the Quality Control of Blood Purification Therapy

> **NCT07291154** · NA · RECRUITING · sponsor: **Yunfeng Xia** · enrollment: 392 (estimated)

## Conditions studied

- End Stage Renal Disease (ESRD)
- Maintenance Hemodialysis

## Interventions

- **BEHAVIORAL:** APP-based management

## Key facts

- **NCT ID:** NCT07291154
- **Lead sponsor:** Yunfeng Xia
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-09-22
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 392 (ESTIMATED)
- **Last updated:** 2025-12-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07291154

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07291154, "Impact of APP-assisted Patient Management on the Quality Control of Blood Purification Therapy". Retrieved via AI Analytics 2026-08-02 from https://api.ai-analytics.org/clinical/NCT07291154. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*